Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.
(Q46926139)
scientific article published in March 2008
scientific article published in March 2008
Language:
Current Data About
Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.